Related Experiment Video
Updated: Sep 4, 2026
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Isolation of a new soluble antigen from the yeast phase of Histoplasma capsulatum
Abstract:
A method is described by which a soluble antigen was prepared from the yeast phase of Histoplasma capsulatum. This soluble preparation had a specificity greater than that of whole-cell yeast-phase antigens. In complement fixation tests with sera from human cases of histoplasmosis, blastomycosis, and coccidioidomycosis, the soluble antigen reacted in 12.1% of 141 tests with heterologous sera, whereas conventional whole-cell yeast antigens reacted in 47.3% of 91 tests with heterologous sera. The reactivities of the two types of antigens with homologous sera were essentially the same.
Insights
A new soluble antigen from Histoplasma capsulatum yeast shows improved specificity in diagnosing fungal infections. This advance reduces false positives in complement fixation tests compared to traditional whole-cell antigens.
Area of Science:
- Mycology
- Immunology
- Diagnostic Microbiology
Background:
- Histoplasmosis is a significant fungal infection.
- Accurate serological diagnosis is crucial for differentiating fungal infections.
- Current diagnostic antigens may lack specificity, leading to cross-reactivity.
Purpose of the Study:
- To develop and evaluate a more specific soluble antigen from the yeast phase of Histoplasma capsulatum.
- To compare the diagnostic specificity of the new soluble antigen with conventional whole-cell yeast antigens.
Main Methods:
- Preparation of a soluble antigen from the yeast phase of Histoplasma capsulatum.
- Performance of complement fixation tests using both the soluble antigen and conventional whole-cell yeast antigens.
- Testing with sera from patients with histoplasmosis, blastomycosis, and coccidioidomycosis.
Main Results:
- The soluble antigen demonstrated significantly greater specificity than whole-cell yeast antigens.
- The soluble antigen showed a lower rate of reaction with heterologous sera (12.1%) compared to whole-cell antigens (47.3%).
- Reactivity with homologous sera was comparable between the soluble and whole-cell antigens.
Conclusions:
- The novel soluble antigen from Histoplasma capsulatum yeast offers enhanced specificity for serological diagnosis.
- This improved specificity can help reduce misdiagnosis by minimizing cross-reactivity with other fungal infections.
- The soluble antigen represents a valuable tool for more accurate detection of histoplasmosis.
